News

Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM™ Subcutaneous Implantable Defibrillator and EMPOWER™ Leadless Pacemaker

The PREDIMAR study, led by researchers at the University of Navarra, University Hospital HM Monteprincipe, Virgen de las Nieves Hospital and General Hospital of Alicante in Spain, is one of the few trials to evaluate the effects of a specific...

Safer and faster procedures: New data from three late-breaking clinical trials continues to support pulsed field ablation as a superior treatment option for atrial fibrillation

HRS late breaking data: SPHERE Per-AF trial demonstrates novel all-in-one system delivers exceptional results, plus increased efficiency and improved quality of life

The Heart Rhythm Society leads an international group of experts in outlining strategies for the evaluation and treatment of arrhythmias, facilitating athletes’ safe participation in sports

Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower costs

Global LEADR clinical trial meets safety and effectiveness objectives; results presented at Heart Rhythm 2024 and simultaneously published in Heart Rhythm

ST. LOUIS, May 15, 2024 – Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has been invited to present at HRS Africa Summit 2024, scheduled to...

Analysis conducted on a hierarchical endpoint comprised of mortality, HF hospitalization, and health status shows that patients treated with phrenic nerve stimulation may be nearly five times as likely to experience a clinical benefit...